文摘
Advanced leads of an imidazopyridine series of positive allosteric modulators of the metabotropic glutamate 2 (mGlu2) receptor are reported. The optimization of in vitro ADMET and in vivo pharmacokinetic properties led to the identification of 27o. With good potency and selectivity for the mGlu2 receptor, 27o affected sleep鈥搘ake architecture in rats after oral treatment, which we have previously shown to be indicative of mGlu2 receptor-mediated central activity.